Humana Inc (HUM)

Currency in USD
198.37
+2.16(+1.10%)
Closed·
198.44+0.07(+0.04%)
·
Earnings results expected in 13 days
HUM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
193.00198.74
52 wk Range
163.11315.35
Key Statistics
Prev. Close
196.21
Open
196.73
Day's Range
193-198.74
52 wk Range
163.11-315.35
Volume
1.29M
Average Vol. (3m)
2.19M
1-Year Change
-30.5451%
Book Value / Share
146.81
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HUM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
212.92
Upside
+7.33%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Healthcare Providers & Services industry

Humana Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Humana Inc SWOT Analysis


Regulatory Roulette
Learn how ongoing Stars ratings litigation and conservative projections impact Humana's growth prospects, while the company navigates a complex healthcare regulatory landscape
Strategic Horizons
Delve into Humana's plan to achieve top-quartile Stars performance by 2028, potentially boosting EPS to $37-$44, with a focus on operational efficiency and CenterWell expansion
Financial Fortitude
Explore Humana's strong financial health, with more cash than debt and a "GOOD" overall score, despite recent stock volatility and analyst target ranges of $250-$353
Medicare Maverick
Humana, a $30B market cap giant, dominates Medicare Advantage while facing regulatory hurdles and pursuing ambitious growth targets amidst fierce competition
Read full SWOT analysis

Humana Inc Earnings Call Summary for Q3/2025

  • Humana's Q3 2025 earnings exceeded forecasts with EPS of $3.24 (14.49% above expectations) and revenue of $32.65 billion, despite stock falling 5.38% in premarket trading.
  • The company reaffirmed its full-year adjusted EPS guidance of approximately $17 while warning of elevated medical costs (mid-single digits) and pharmacy costs (low double digits) in 2026.
  • Humana completed a non-core asset sale and is investing approximately $150 million in incremental growth initiatives, maintaining a debt-to-capital ratio of 40.3%.
  • CEO Jim Rechtin emphasized focus on 'maximizing customer lifetime value' over short-term membership targets, with the company exploring dual-eligible Medicaid opportunities in several states.
  • Management expressed confidence in STARS recovery efforts, aiming to return to the top quartile by bonus year 2028, while balancing long-term value creation with quarterly performance.
Last Updated: 11/05/2025, 09:22 AM
Read Full Transcript

Compare HUM to Peers and Sector

Metrics to compare
HUM
Peers
Sector
Relationship
P/E Ratio
20.0x17.3x−0.5x
PEG Ratio
−14.07−0.800.00
Price / Book
1.3x1.7x2.6x
Price / LTM Sales
0.2x1.3x3.2x
Upside (Analyst Target)
5.2%−0.9%45.7%
Fair Value Upside
Unlock−4.4%4.8%Unlock

Analyst Ratings

8 Buy
17 Hold
2 Sell
Ratings:
27 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 212.92
(+7.33% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Baird
Hold205.00+3.34%264.00MaintainApr 15, 2026
Truist Securities
Hold220.00+10.90%200.00MaintainApr 13, 2026
Evercore ISI
Hold195.00-1.70%180.00MaintainApr 08, 2026
Mizuho
Buy258.00+30.06%310.00MaintainApr 08, 2026
Cantor Fitzgerald
Hold201.00+1.33%-MaintainApr 07, 2026

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 9.84%
Dividend Yield
1.79%
Industry Median 2.48%
Annualized Payout
3.54
Paid quarterly
5-Years Growth
+7.20%
Growth Streak

Earnings

Latest Release
Feb 11, 2026
EPS / Forecast
-3.96 / -4.00
Revenue / Forecast
32.52B / 32.04B
EPS Revisions
Last 90 days

HUM Income Statement

People Also Watch

389.72
INTU
+6.25%
61.29
FISV
+3.85%
314.05
UNH
-0.04%
891.72
SNDK
-5.58%
37.60
CNC
+0.91%

FAQ

What Is the Humana (HUM) Stock Price Today?

The Humana stock price today is 198.37 USD.

What Stock Exchange Does Humana Trade On?

Humana is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Humana?

The stock symbol for Humana is "HUM."

Does Humana Pay Dividends? What’s The Current Dividend Yield?

The Humana dividend yield is 1.79%.

What Is the Humana Market Cap?

As of today, Humana market cap is 23.80B USD.

What Is Humana's Earnings Per Share (TTM)?

The Humana EPS (TTM) is 9.84.

When Is the Next Humana Earnings Date?

Humana will release its next earnings report on Apr 29, 2026.

From a Technical Analysis Perspective, Is HUM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Humana Stock Split?

Humana has split 8 times.

How Many Employees Does Humana Have?

Humana has 67060 employees.

What is the current trading status of Humana (HUM)?

As of Apr 16, 2026, Humana (HUM) is trading at a price of 198.37 USD, with a previous close of 196.21 USD. The stock has fluctuated within a day range of 193.00 USD to 198.74 USD, while its 52-week range spans from 163.11 USD to 315.35 USD.

What Is Humana (HUM) Price Target According to Analysts?

The average 12-month price target for Humana is 212.92 USD, with a high estimate of 333 USD and a low estimate of 146 USD. 8 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +7.33% Upside potential.

What Is the HUM Premarket Price?

HUM's last pre-market stock price is 196.00 USD. The pre-market share volume is 1,800.00, and the stock has decreased by -0.21, or -0.11%.

What Is the HUM After Hours Price?

HUM's last after hours stock price is 198.44 USD, the stock has decreased by 0.07, or 0.04%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.